Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers G Cammu, P.J. De Kam, I Demeyer, M Decoopman, P.A.M. Peeters, J.M.W. Smeets, L Foubert British Journal of Anaesthesia Volume 100, Issue 3, Pages 373-379 (March 2008) DOI: 10.1093/bja/aem402 Copyright © 2008 British Journal of Anaesthesia Terms and Conditions
Fig 1 Semi log plots of plasma concentrations of sugammadex vs time after simultaneous administration with rocuronium 1.2 mg kg−1 (a) or vecuronium 0.1 mg kg−1 (b). British Journal of Anaesthesia 2008 100, 373-379DOI: (10.1093/bja/aem402) Copyright © 2008 British Journal of Anaesthesia Terms and Conditions
Fig 2 Semi log plots of plasma concentrations of rocuronium 1.2 mg kg−1 (a) or vecuronium 0.1 mg kg−1 (b) vs time after simultaneous administration with sugammadex. NMBA, neuromuscular blocking agent. British Journal of Anaesthesia 2008 100, 373-379DOI: (10.1093/bja/aem402) Copyright © 2008 British Journal of Anaesthesia Terms and Conditions
Fig 3 Molar ratios (ratio of concentrations in moles) of sugammadex/rocuronium (a) and sugammadex/vecuronium (b) vs time after simultaneous administration. NMBA, neuromuscular blocking agent. British Journal of Anaesthesia 2008 100, 373-379DOI: (10.1093/bja/aem402) Copyright © 2008 British Journal of Anaesthesia Terms and Conditions